Showing results (1-10 of 215) with videos related to

Sort By:
Pageof 22
Immunotherapy|April 6, 2013
Targeting EBV's Achilles' heel with antigen-specific T cellsMamta Kalra, Stephen Gottschalk
Cytotherapy|November 7, 2018
Epstein-Barr Virus (EBV)-derived BARF1 encodes CD4- and CD8-restricted epitopes as targets for T-cell immunotherapyMamta Kalra, Ulrike Gerdemann, Jessica D Luu, et al.
Expert Review of Vaccines|April 29, 2009
How to design effective vaccines: lessons from an old success storyNabil Ahmed, Stephen Gottschalk
Science (New York, N.Y.)|June 19, 2025
Engineering immunotherapy from withinVivek Peche, Stephen Gottschalk
Cancer Journal (Sudbury, Mass.)|March 27, 2014
CAR T cells for solid tumors: armed and ready to go?Sunitha Kakarla, Stephen Gottschalk
Advances in Experimental Medicine and Biology|June 14, 2014
Genetically modified T-cell therapy for osteosarcomaChristopher DeRenzo, Stephen Gottschalk
Med (New York, N.Y.)|June 11, 2022
CAR T cell therapy for solid tumors: Fatal attraction requires adhesionMatthew Bell, Stephen Gottschalk
Advances in Experimental Medicine and Biology|June 3, 2020
Genetically Modified T-Cell Therapy for Osteosarcoma: Into the Roaring 2020sChristopher DeRenzo, Stephen Gottschalk
Immunotherapy|January 10, 2015
Adoptive cell therapy for sarcomaMelinda Mata, Stephen Gottschalk
Frontiers in Immunology|June 28, 2021
Engineered Cytokine Signaling to Improve CAR T Cell Effector FunctionMatthew Bell, Stephen Gottschalk
Pageof 22